Voluntary Recall Information
Philips Respironics Sleep and Respiratory Care devices
Important information for clinicians
Sleep Therapy information
Our progress in completing actionable registrations across sleep therapy and ventilation devices marks an important milestone in the June 2021 recall.
As a result of this progress, the US Patient Portal for affected CPAP and BiPAP devices is no longer available as of January 1, 2026.
We will continue to prioritize remediation of registered sleep and respiratory care devices and will also continue to accept returned affected devices at no cost.
Ventilation information
The remediation of ventilator devices remains ongoing. Philips Respironics will communicate with Durable Medical Equipment providers (DMEs) as updates become available. Please visit our ventilation news and updates page for the latest information.
Latest Testing Updates
Test results and conclusions for home sleep therapy devices Based on the results to date, Philips Respironics and the third-party experts concluded that use of the sleep therapy devices is not expected to result in appreciable harm to health in patients. Further testing related to the sleep therapy and ventilator devices remain ongoing. Since the start of the test and research program, Philips Respironics has worked cooperatively with the FDA on the program and to publish regular test updates as agreed with the FDA. The latest update can be found here.
Ozone and UV light cleaning products are not currently approved cleaning methods for sleep apnea devices, ventilators, or masks and should not be used.
At Philips, patient safety and quality are at the heart of everything we do
Latest updates
Explained: The voluntary Philips Respironics sleep and respiratory care devices recall*
* This is a voluntary recall notification in the US and field safety notice in other countries
Explained: The Philips Respironics Consent Decree
April 4, 2024
